Cassava Sciences | PTIE - Ordinary Share Capital


Cassava Sciences reported $48.31M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Amgen USD 539M 1000K Dec/2025
Biogen USD 146.7M 200K Sep/2025
Cara Therapeutics USD 2K 3K Mar/2025
Cassava Sciences USD 48.31M 48.26M Sep/2025
Eisai JPY 282.11M 1000 Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Geron USD 638.02M 637.38M Sep/2025
J&J USD 2.41B 584K Sep/2025
Merck USD 2.49B 15.79M Sep/2025
Novartis USD 1.94B 23.4M Jun/2025
Novavax USD 1.62M 211K Sep/2024
Pfizer USD 5.69B 1000K Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025